Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: semi-recumbent who wrote (1605)	1/28/2000 7:30:00 PM
From: Richaaard	Read Replies (1) of 1837

At this rate (Cenestin) it would take 3 1/2 years to achieve 5% of the market, far less than projections. Why do I get the idea that little has been done since Solvay came on board to actively market this drug? It seems to me as though if Solvay owned Duramed the marketting would be stepped up. I know I'm leaving myself open for attack but I'm not sure that I trust Solvay. If they had an interest in acquiring DRMD they would have a better chance if DRMD price stayed low, which it has. If I wanted to buy another company I surely would think twice about pumping up their share value first via drug sales. Comments?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next